Acid sphingomyelinase-deficient mice were almost completely protected against the induction of an experimental multiple sclerosis, i.e. experimental autoimmune encephalomyelitis (1, 2). This evidence concerns the gene SMPD1 and experimental autoimmune encephalomyelitis.